Skip to main content

Table 1 Multidrug resistance, resistance to chlorhexidine and resistance to methicillin from 211 clinical isolates of CoNS by species

From: Decreased susceptibility to chlorhexidine and distribution of qacA/B genes among coagulase-negative Staphylococcus clinical samples

Species

n (%)

MDR n (%)

MIC of CHX ≥ 4 mg/L n (%)

MIC of CHX ≥ 4 mg/L and MR n (%)

S. epidermidis

65 (31)

54 (83)

25 (38.4)

22 (33,8)

S. hominis hominis

32 (15.1)

26 (81)

10 (31.2)

10 (31,2)

S. auricularis

25 (12)

24 (96)

13 (52)

11 (44)

S. haemolyticus

24 (11.3)

21 (87.5)

8 (33.3)

8 (33,3)

S. capitis urealyticus

11 (5.2)

10 (91)

4 (36.3)

4 (36,3)

S. saccharolyticus

5 (2.3)

4 (80)

1 (20)

1 (20)

S. chonii urealyticum

5 (2.3)

5 (100)

0

0

S. cohnii cohnii

4 (1.8)

4 (100)

0

0

S. saprophyticus

4 (1.8)

4 (100)

1 (25)

1 (25)

S. capitis capitis

3 (1.4)

3 (100)

1 (33.3)

1 (33,3)

S. chromogenes

2 (1.4)

2 (100)

0

0

S. xylosus

1 (0.4)

1 (100)

0

0

S. simulans

1 (0.4)

1 (100)

0

0

S. sciuri

1 (0.4)

1 (100)

0

0

Unidentified CoNS

28 (13.2)

24 (85.7)

2 (7.1)

2 (7,1)

Total

211 (100)

184 (87)

65 (31)

60 (28,4)

  1. MRD multidrug resistance, MIC minimum inhibitory concentration, CHX chlorhexidine, CoNS Coagulase-negative staphylococci, MR Methicillin-resistant